Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
EMBO Rep ; 23(9): e55375, 2022 09 05.
Artículo en Inglés | MEDLINE | ID: mdl-35852463

RESUMEN

Stem cells intrinsically express a subset of genes which are normally associated with interferon stimulation and the innate immune response. However, the expression of these interferon-stimulated genes (ISG) in stem cells is independent from external stimuli such as viral infection. Here, we show that the interferon regulatory factor 1, Irf1, is directly controlled by the murine formative pluripotency gene regulatory network and transiently upregulated during the transition from naive to formative pluripotency. IRF1 binds to regulatory regions of a conserved set of ISGs and is required for their faithful expression upon exit from naive pluripotency. We show that in the absence of IRF1, cells exiting the naive pluripotent stem cell state are more susceptible to viral infection. Irf1 therefore acts as a link between the formative pluripotency network, regulation of innate immunity genes, and defense against viral infections during formative pluripotency.


Asunto(s)
Células Madre Pluripotentes , Virosis , Animales , Antivirales , Factor 1 Regulador del Interferón/genética , Factor 1 Regulador del Interferón/metabolismo , Interferones/metabolismo , Ratones , Células Madre Pluripotentes/metabolismo , Regulación hacia Arriba , Virosis/genética , Virosis/metabolismo
2.
J Clin Sleep Med ; 13(10): 1131-1136, 2017 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-28859717

RESUMEN

STUDY OBJECTIVES: Erythrocyte levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Omega-3 Index) were previously found to be associated with obstructive sleep apnea (OSA) at very low levels (< 5.0%) in only one epidemiologic study. OSA has comorbidities, such as arterial hypertension, heart failure, or major depression, also associated with a low Omega-3 Index. These comorbidities can be improved by increasing intake of EPA and DHA, and thus the Omega-3 Index, preferably to its target range of 8% to 11%. Symptoms of OSA might improve by increasing the Omega-3 Index, but more research is needed. METHODS: In our sleep laboratory, 357 participants with OSA were recruited, and data from 315 participants were evaluated. Three categories of OSA (none/ mild, moderate, severe) were defined based on apnea-hypopnea index. Anthropometrics and lifestyle characteristics (smoking, alcohol, fish intake, omega-3 supplementation) were recorded. Erythrocyte fatty acid compositions were assessed with the HS-Omega-3 Index methodology. RESULTS: The mean Omega-3 Index in all 3 categories of OSA was 5.7%, and no association with OSA was found. There were more male participants with severe OSA (79.7%, P = .042) than females, and participants with severe OSA had a significantly higher body mass index (32.11 ± 6.39 kg/m2, P = .009) than participants with mild or moderate OSA. Lifestyle characteristics were not significantly different. CONCLUSIONS: In contrast to our hypothesis, an Omega-3 Index of 5.7% was not associated with OSA severity. Previously, an Omega-3 Index < 5.0% was associated. Although our results suggest aiming for an Omega-3 Index > 5.7% in an intervention trial with EPA and DHA in OSA, comorbidities of OSA suggest a target range of 8% to 11%.


Asunto(s)
Ácidos Grasos Omega-3/sangre , Apnea Obstructiva del Sueño/sangre , Adulto , Anciano , Anciano de 80 o más Años , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad
3.
Anal Biochem ; 473: 11-3, 2015 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-25479603

RESUMEN

Sample preparation prior to analysis by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) usually involves the storage of frozen peptide samples in an acidic environment for variable time periods. Questions arose in our laboratory regarding the stability of peptides in acid under medium- to long-term storage. Thus, a 10-month longitudinal study was designed to assess the effect on storage of tryptic peptides at -20 and -80°C under acidic conditions. Our conclusion and proposal from this evaluation is that the optimal storage conditions of peptide samples in acid for proteomic experiments is at -80°C and, ideally, as separate aliquots.


Asunto(s)
Péptidos/química , Proteolisis , Proteómica , Secuencia de Aminoácidos , Métodos Analíticos de la Preparación de la Muestra , Animales , Bovinos , Frío , Estabilidad de Medicamentos , Concentración de Iones de Hidrógeno , Factores de Tiempo
4.
J Proteome Res ; 13(2): 1147-55, 2014 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-24400740

RESUMEN

Affinity purification coupled to 1-D gel-free liquid chromatography mass spectrometry (LC-MS) is a well-established and widespread approach for the analyses of noncovalently interacting protein complexes. In this study, two proteins conjugated to a streptavidin-binding peptide and hemagglutinin double tag were expressed in the respective Flp-In HEK293 cell lines: green fluorescent protein (SH-GFP) and TANK binding kinase 1 (SH-TBK1_MOUSE). Fluorescent anti-HA immunoblots revealed that the expression level of SH-GFP was ∼50% lower than that of SH-TBK1_MOUSE. Subsequently, the input material was normalized to obtain a similar quantity of purified SH-tagged proteins. Optimization of the release of protein complexes from the anti-HA-agarose with different eluting agents was then assessed. With respect to the total number of protein groups identified in the purified complexes, elution with 2% SDS surpassed both 100 mM glycine and 100 mM formic acid. Relative quantitation of the purified protein complexes using TMT 6-plex reagents confirmed the higher efficiency of the 2% SDS elution followed by filter-aided sample preparation (FASP). The data presented in this study provide a new application of FASP to quantitative MS analysis of affinity-purified protein complexes. We have termed the approach abFASP-MS, or affinity-based filter-aided sample preparation mass spectrometry.


Asunto(s)
Proteínas/análisis , Espectrometría de Masas en Tándem/métodos , Western Blotting , Cromatografía de Afinidad , Cromatografía de Fase Inversa , Electroforesis en Gel de Poliacrilamida , Proteínas/química , Tripsina/química
5.
Anal Chem ; 85(3): 1454-61, 2013 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-23301806

RESUMEN

The identification and validation of cross-linked peptides by mass spectrometry remains a daunting challenge for protein-protein cross-linking approaches when investigating protein interactions. This includes the fragmentation of cross-linked peptides in the mass spectrometer per se and following database searching, the matching of the molecular masses of the fragment ions to the correct cross-linked peptides. The hybrid linear trap quadrupole (LTQ) Orbitrap Velos combines the speed of the tandem mass spectrometry (MS/MS) duty circle with high mass accuracy, and these features were utilized in the current study to substantially improve the confidence in the identification of cross-linked peptides. An MS/MS method termed multiple and sequential data acquisition method (MSDAM) was developed. Preliminary optimization of the MS/MS settings was performed with a synthetic peptide (TP1) cross-linked with bis[sulfosuccinimidyl] suberate (BS(3)). On the basis of these results, MSDAM was created and assessed on the BS(3)-cross-linked bovine serum albumin (BSA) homodimer. MSDAM applies a series of multiple sequential fragmentation events with a range of different normalized collision energies (NCE) to the same precursor ion. The combination of a series of NCE enabled a considerable improvement in the quality of the fragmentation spectra for cross-linked peptides, and ultimately aided in the identification of the sequences of the cross-linked peptides. Concurrently, MSDAM provides confirmatory evidence from the formation of reporter ions fragments, which reduces the false positive rate of incorrectly assigned cross-linked peptides.


Asunto(s)
Fragmentos de Péptidos/análisis , Estadística como Asunto/métodos , Espectrometría de Masas en Tándem/métodos , Secuencia de Aminoácidos , Animales , Bovinos , Espectrometría de Masas/métodos , Datos de Secuencia Molecular , Fragmentos de Péptidos/genética , Albúmina Sérica Bovina/análisis , Albúmina Sérica Bovina/genética
6.
Nat Protoc ; 8(1): 75-97, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23237831

RESUMEN

Protein complexes form, dissociate and re-form in order to perform specific cellular functions. In this two-pronged protocol, noncovalent protein complexes are initially isolated by affinity purification for subsequent identification of the components by liquid chromatography high-resolution mass spectrometry (LC-MS) on a hybrid LTQ Orbitrap Velos. In the second prong of the approach, the affinity-purification strategy includes a chemical cross-linking step to 'freeze' a series of concurrently formed, heterogeneous protein subcomplex species that are visualized by gel electrophoresis. This branch of the methodology amalgamates standard and well-practiced laboratory methods to reveal compositional changes that occur in protein complex architecture. By using mouse N-terminally tagged streptavidin-binding peptide-hemagglutinin-TANK-binding kinase 1 (SH-TBK1), we chemically cross-linked the affinity-purified complex of SH-TBK1 with the homobifunctional lysine-specific reagent bis(sulfosuccinimidyl) suberate (BS(3)), and we separated the resultant protein complexes by denaturation and by silver-stained one- and two-dimensional SDS-PAGE. We observed a range of cross-linked TBK1 complexes of variable pI and M(r) and confirmed them by immunoblotting. LC-MS analysis of in situ-digested cross-linked proteins shows differences in the composition of the TBK1 subcomplexes. The protocol is inherently simple and can be readily extended to the investigation of a range of protein complexes. From cell lysis to data generation by LC-MS, the protocol takes approximately 2.5 to 5.5 d to perform.


Asunto(s)
Cromatografía de Afinidad/métodos , Hemaglutininas/química , Proteínas Serina-Treonina Quinasas/química , Proteínas/química , Algoritmos , Animales , Proteínas Portadoras , Cromatografía Liquida/métodos , Reactivos de Enlaces Cruzados , Bases de Datos de Proteínas , Electroforesis en Gel de Poliacrilamida , Células HEK293 , Humanos , Espectrometría de Masas/métodos , Ratones , Vanadatos/química
7.
J Proteome Res ; 12(2): 1040-8, 2013 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-23214492

RESUMEN

The performance of two proteomic sample preparation methods, "pseudoshotgun" (PSG) and filter-aided sample preparation (FASP) were compared in terms of the number of identified proteins, representation of cellular component GO (gene ontology) categories in the obtained list of proteins, and the efficiency of both methods in the proteomic analysis of a very low number of cells. Both methods were combined to obtain a proteomic profile of a short-term culture (passage 3) of melanoma cells, established in our laboratory from a human metastatic melanoma lesion. The data revealed that with FASP, usually more proteins are identified than with PSG when analyzing a higher number of cells (≥ 5000/injection), whereas PSG is favorable when analyzing only a very small amount of cells (250-500/injection). PSG and FASP, however, are complementary techniques, as combining both methods further increases the number of identified proteins. Moreover, we show that it is feasible to identify a substantial number of proteins from only 250 cells/injection that is equivalent to 60 ng of protein.


Asunto(s)
Melanoma/química , Proteínas de Neoplasias/aislamiento & purificación , Fragmentos de Péptidos/aislamiento & purificación , Proteoma/aislamiento & purificación , Neoplasias Cutáneas/química , Recuento de Células , Cromatografía Liquida , Filtración/métodos , Humanos , Límite de Detección , Melanoma/secundario , Proteínas de Neoplasias/química , Proteolisis , Proteoma/química , Neoplasias Cutáneas/patología , Espectrometría de Masas en Tándem , Tripsina/química , Células Tumorales Cultivadas
8.
Proteomics ; 12(22): 3338-42, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22997067

RESUMEN

The 5-hydroxytryptamine 1A receptor (serotonin 1A receptor; 5-HT(1A) R) is involved in a large series of brain functions, and roles in anxiety, depression, and cognition have been reported. So far, published information on mass spectrometrical characterization of 5-HT(1A) R is limited to the presence of two 5-HT(1A) R peptides in rat's whole brain as observed by in-solution digestion followed by LC-MS/MS. Knowledge about the protein sequence and PTMs, however, would have implications for generation of specific antibodies and designing studies on the 5-HT(1A) R at the protein level. A rat recombinant 5-HT(1A) R was extracted from the tsA201 cell line, run using several gel-based principles with subsequent in-gel digestion with several proteases, chymotrypsin, trypsin, AspN, proteinase K, and pepsin followed by nano-LC-ESI-MS/MS analysis on a high capacity ion trap and an LTQ Orbitrap Velos. Using two search engines, Mascot and Modiro™, the recombinant 5-HT(1A) R was identified showing 94.55% sequence coverage. A single phosphorylation at S301 was identified and verified by phosphatase treatment and a series of amino acid substitutions were detected. Characterization of 5-HT(1A) R, a key player of brain functions and neurotransmission, was shown and may enable generation of specific antibodies, design of future, and interpretation of previous studies in the rat at the protein level.


Asunto(s)
Receptor de Serotonina 5-HT1A/química , Proteínas Recombinantes/química , Espectrometría de Masas en Tándem/métodos , Sustitución de Aminoácidos , Animales , Línea Celular , Humanos , Inmunoprecipitación , Riñón/citología , Riñón/metabolismo , Fragmentos de Péptidos/análisis , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Proteómica , Ratas , Receptor de Serotonina 5-HT1A/aislamiento & purificación , Receptor de Serotonina 5-HT1A/metabolismo , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Espectrometría de Masa por Ionización de Electrospray/métodos
9.
J Natl Cancer Inst ; 104(4): 273-9, 2012 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-22232132

RESUMEN

Sipuleucel-T was approved by the US Food and Drug Administration on April 29, 2010, as an immunotherapy for late-stage prostate cancer. To manufacture sipuleucel-T, mononuclear cells harvested from the patient are incubated with a recombinant prostatic acid phosphatase (PAP) antigen and reinfused. The manufacturer proposes that antigen-presenting cells exogenously activated by PAP induce endogenous T-cells to attack PAP-bearing prostate cancer cells. However, the lack of demonstrable tumor responses has prompted calls for scrutiny of the design of the trials in which sipuleucel-T demonstrated a 4-month survival benefit. Previously unpublished data from the sipuleucel-T trials show worse overall survival in older vs younger patients in the placebo groups, which have not been shown previously to be prognostic for survival in castration-resistant prostate cancer patients receiving chemotherapy. Because two-thirds of the cells harvested from placebo patients, but not from the sipuleucel-T arm, were frozen and not reinfused, a detrimental effect of this large repeated cell loss provides a potential alternative explanation for the survival "benefit." Patient safety depends on adequately addressing this alternative explanation for the trial results.


Asunto(s)
Envejecimiento , Vacunas contra el Cáncer/uso terapéutico , Inmunoterapia/métodos , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Neoplasias de la Próstata/tratamiento farmacológico , Proteínas Tirosina Fosfatasas/metabolismo , Extractos de Tejidos/uso terapéutico , Fosfatasa Ácida , Factores de Edad , Anciano , Anciano de 80 o más Años , Vacunas contra el Cáncer/efectos adversos , Ensayos Clínicos como Asunto , Humanos , Inmunoterapia/efectos adversos , Masculino , Persona de Mediana Edad , Neoplasias Hormono-Dependientes/inmunología , Neoplasias Hormono-Dependientes/mortalidad , Selección de Paciente , Pronóstico , Neoplasias de la Próstata/inmunología , Neoplasias de la Próstata/mortalidad , Proyectos de Investigación , Análisis de Supervivencia , Extractos de Tejidos/efectos adversos
10.
Metabolism ; 59(7): 1020-8, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20045149

RESUMEN

Insulin causes inotropic effects via Ca(2+)-dependent and Ca(2+)-independent pathways. The latter one is potentially glucose dependent. We examined inotropic responses and signal transduction of insulin in human atrial myocardium of diabetic and nondiabetic patients to test for the role of glucose transporters. Experiments were performed in isolated atrial myocardium of 88 patients undergoing cardiac surgery and 28 ventricular muscle samples of explanted hearts. Influence of insulin (0.02 micromol/L) on isometric twitch force was examined with and without blocking glucose transporter (GLUT) 4 translocation (latrunculin), sodium-coupled glucose transporter (SGLT) 1 (phlorizin, T-1095A), or PI3-kinase (wortmannin). Experiments were performed in Tyrode solution containing glucose or pyruvate as energetic substrate. Messenger RNA expression of glucose transporters (GLUT1, GLUT4, SGLT1, SGLT2) was analyzed in atrial and ventricular myocardium of both diabetic and nondiabetic patients. Developed force increases after insulin (to 117.8% +/- 2.4% and 115.8% +/- 1.9%) in trabeculae from patients with and without diabetes. Inotropic effect was reduced after displacing glucose with pyruvate as well as after PI3-kinase inhibition (to 103% +/- 2%) or inhibition of glucose transporters GLUT4 (to 105% +/- 2%) and SGLT1 (phlorizin to 106% +/- 2%, T-1095A to 105% +/- 2%), without differences between the 2 groups. In glucose-free pyruvate-containing solution, only inhibition of PI3-kinase but not blocking glucose transporters resulted in further inhibitory effects. Messenger RNA expression did not show significant differences between patients with or without diabetes. Insulin exerts positive inotropic effects in human atrial myocardium. These effects are mediated via a PI3-kinase-sensitive and a glucose-transport-sensitive pathway. Differences in functional effects or messenger RNA expression of glucose transporters were not detectable between patients with and without diabetes.


Asunto(s)
Diabetes Mellitus/fisiopatología , Proteínas Facilitadoras del Transporte de la Glucosa/fisiología , Contracción Miocárdica/fisiología , Anciano , Cardiotónicos/farmacología , Diabetes Mellitus/metabolismo , Femenino , Glucosa/metabolismo , Proteínas Facilitadoras del Transporte de la Glucosa/biosíntesis , Proteínas Facilitadoras del Transporte de la Glucosa/genética , Atrios Cardíacos , Humanos , Hipoglucemiantes/farmacología , Técnicas In Vitro , Insulina/farmacología , Masculino , Persona de Mediana Edad , Miocardio/citología , Miocardio/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Ácido Pirúvico/metabolismo , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Transportador 1 de Sodio-Glucosa/biosíntesis , Transportador 1 de Sodio-Glucosa/genética
11.
Eur J Heart Fail ; 12(2): 106-13, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20083620

RESUMEN

AIMS: Insulin-dependent positive inotropic effects (PIE) are partially Ca(2+) independent. This mechanism is potentially glucose dependent. In contrast to most animal species, human myocardium expresses high levels of sodium-glucose-transporter-1 (SGLT-1) mRNA besides the common glucose-transporters-1 and -4 (GLUT1, GLUT4). METHODS AND RESULTS: We used ventricular myocardium from 61 end-stage failing human hearts (ischaemic cardiomyopathy, ICM and dilated cardiomyopathy, DCM) and 13 non-failing donor hearts. The effect of insulin on isometric twitch force was examined with or without blocking of PI3-kinase, GLUT4-translocation, or SGLT-1. Substrate-dependent (glucose vs. pyruvate vs. palmitoyl-carnitine) effects were tested in atrial myocardium. mRNA expression of glucose transporters was analysed. Insulin increased developed force by 122 + or - 7.4, 121.7 + or - 2.5, and 134.1 + or - 5.7% in non-failing, DCM, and ICM (P < 0.05 vs. DCM), respectively. Positive inotropic effect was partially blunted by inhibition of PI-3-kinase, GLUT4, or SGLT1. Combined inhibition of PI3-kinase and glucose-transport completely abolished PIE. Positive inotropic effect was significantly stronger in glucose-containing solution compared with pyruvate or palmitoyl-carnitine containing. mRNA expression showed only a tendency towards elevated GLUT4-expression in ICM. CONCLUSIONS: Positive inotropic effect of insulin is pronounced in ICM, but underlying mechanisms are unaltered. The Ca(2+)-independent PIE of insulin is mediated via glucose-transporters. Together with the Ca(2+)-dependent PI-3-kinase mediated pathway, it is responsible for the entire PIE. Substrate-dependency affirms a glucose-dependent part of the PIE.


Asunto(s)
Transportador de Glucosa de Tipo 1/metabolismo , Transportador de Glucosa de Tipo 4/metabolismo , Insuficiencia Cardíaca/fisiopatología , Contracción Miocárdica/fisiología , Miocardio/metabolismo , Transportador 1 de Sodio-Glucosa/metabolismo , Anciano , Carbonatos/farmacología , Cardiomiopatía Dilatada/fisiopatología , Relación Dosis-Respuesta a Droga , Femenino , Regulación de la Expresión Génica , Transportador de Glucosa de Tipo 1/genética , Transportador de Glucosa de Tipo 4/genética , Glucósidos/farmacología , Ventrículos Cardíacos , Humanos , Técnicas In Vitro , Concentración 50 Inhibidora , Insulina/farmacología , Masculino , Persona de Mediana Edad , Contracción Miocárdica/efectos de los fármacos , Isquemia Miocárdica/fisiopatología , Inhibidores de las Quinasa Fosfoinosítidos-3 , ARN Mensajero/metabolismo , Transportador 1 de Sodio-Glucosa/antagonistas & inhibidores , Transportador 1 de Sodio-Glucosa/genética , Transportador 2 de Sodio-Glucosa/genética , Transportador 2 de Sodio-Glucosa/metabolismo , Inhibidores del Cotransportador de Sodio-Glucosa 2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...